ly 255283 has been researched along with arginine vasopressin in 1 studies
| Studies (ly 255283) | Trials (ly 255283) | Recent Studies (post-2010) (ly 255283) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
|---|---|---|---|---|---|
| 54 | 0 | 15 | 12,278 | 422 | 1,212 |
| Protein | Taxonomy | ly 255283 (IC50) | arginine vasopressin (IC50) |
|---|---|---|---|
| Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, X; Kurahashi, K; Nishihashi, T; Trandafir, CC; Wang, A | 1 |
1 other study(ies) available for ly 255283 and arginine vasopressin
| Article | Year |
|---|---|
Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
Topics: Animals; Arginine Vasopressin; Basilar Artery; Benzopyrans; Carboxylic Acids; Female; In Vitro Techniques; Leukotriene Antagonists; Leukotriene B4; Leukotriene C4; Leukotriene D4; Lipoxygenase Inhibitors; Muscle, Smooth, Vascular; Propionates; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Leukotriene; Receptors, Leukotriene B4; Tetrazoles; Vasoconstriction; Vasoconstrictor Agents | 2005 |